Analysis of the prognostic value of emergency blood tests in ischaemic stroke

Autor: Marta-Enguita, J. ^{a, b, c, d, e}, Rubio-Baines, I. ^a, Aymerich, N. ^{a, e}, Herrera, M. ^{a, d, e}, Zandio, B. ^{a, d, e}, Mayor, S. ^a, Roncal, C. ^{b, d, f}, Mendioroz, M. ^{a, d, e, g}, Orbe, J. ^{b, d, e}, Muñoz, R. ^{a, d, e, ⁎}

Publikováno v: In Neurología (English Edition) October 2024 39(8):617-628

La Filosofía de la Educación en Europa F. Barcena Orbe J. M. Barrio Maestre F. Gil Cantero J. A. Ibañez-Martin G. Jover Olmeda M. Ruiz Corbella D. Sacristan Gomez

Publikováno v: International Review of Education / Internationale Zeitschrift für Erziehungswissenschaft / Revue Internationale de l'Education, 1993 Nov 01. 39(6), 578-580.

Externí odkaz: https://www.jstor.org/stable/3444983

Novel protocol for the transcriptomic analysis of endothelial extracellular vesicles in atherosclerosis.

Autor: Saenz-Pipaon G; Laboratorio de Aterotrombosis, Programa de Enfermedades Cardiovasculares, Cima Universidad de Navarra, Pamplona, Spain; IdiSNA, Pamplona, Spain., Cenarro A; Hospital Universitario Miguel Servet, Zaragoza, Spain; Instituto de Investigación Sanitaria Aragón (IIS Aragón), Universidad de Zaragoza, Zaragoza, Spain; CIBERCV, Madrid, Spain., Zazpe J; IdiSNA, Pamplona, Spain; Plataforma de Genómica, Cima Universidad de Navarra, Pamplona, Spain., Goñi-Oloriz M; IdiSNA, Pamplona, Spain; Cardiovascular Translational Research, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Spain., Martinez-Aguilar E; IdiSNA, Pamplona, Spain; Departamento de Angiología y Cirugía Vascular, Hospital Universitario de Navarra, Pamplona, Spain., Machado FJD; Laboratorio de Aterotrombosis, Programa de Enfermedades Cardiovasculares, Cima Universidad de Navarra, Pamplona, Spain., Marchese FP; IdiSNA, Pamplona, Spain; Plataforma de Genómica, Cima Universidad de Navarra, Pamplona, Spain., Orbe J; Laboratorio de Aterotrombosis, Programa de Enfermedades Cardiovasculares, Cima Universidad de Navarra, Pamplona, Spain; IdiSNA, Pamplona, Spain; Ricors Ictus, Madrid, Spain., López-Andrés N; IdiSNA, Pamplona, Spain; Cardiovascular Translational Research, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Spain., Civeira F; Hospital Universitario Miguel Servet, Zaragoza, Spain; Instituto de Investigación Sanitaria Aragón (IIS Aragón), Universidad de Zaragoza, Zaragoza, Spain; CIBERCV, Madrid, Spain., Paramo JA; Laboratorio de Aterotrombosis, Programa de Enfermedades Cardiovasculares, Cima Universidad de Navarra, Pamplona, Spain; IdiSNA, Pamplona, Spain; CIBERCV, Madrid, Spain; Servicio de Hematología, Clínica Universidad de Navarra, Pamplona, Spain., Lara-Astiaso D; Stem Cell Institute, MRC, Cambridge, UK., Roncal C; Laboratorio de Aterotrombosis, Programa de Enfermedades Cardiovasculares, Cima Universidad de Navarra, Pamplona, Spain; IdiSNA, Pamplona, Spain; CIBERCV, Madrid, Spain. Electronic address: croncalm@unav.es.

Publikováno v: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis [Clin Investig Arterioscler] 2024 Nov-Dec; Vol. 36 (6), pp. 343-355. Date of Electronic Publication: 2024 Sep 12.

Comparison of assays measuring extracellular vesicle tissue factor in plasma samples: communication from the ISTH SSC Subcommittee on Vascular Biology.

Autor: Bonifay A; Aix-Marseille University, C2VN, INSERM 1263, INRAE1260, Marseille, France; Department of Hematology and Vascular Biology, CHU La Conception, APHM, Marseille, France., Mackman N; UNC Blood Research Center, Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Hisada Y; UNC Blood Research Center, Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Sachetto ATA; UNC Blood Research Center, Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Hau C; Laboratory of Experimental Clinical Chemistry, and Amsterdam Vesicle Center, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Gray E; National Institute for Biological Standards and Control, Potter's Bar, Hertfordshire, United Kingdom., Hogwood J; National Institute for Biological Standards and Control, Potter's Bar, Hertfordshire, United Kingdom., Aharon A; Hematology Research Laboratory, Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Badimon L; Cardiovascular ICCC Program, Research Institute Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red Cardiovascular (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain., Barile L; Cardiovascular Theranostics, Istituto Cardiocentro Ticino, Laboratories for Translational Research, Ente Ospedaliero Cantonale, Bellinzona, Switzerland; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland., Baudar J; Université Catholique de Louvain, CHU UCL NAMUR, Namur Thrombosis and Hemostasis Center (NTHC), Yvoir, Belgium., Beckmann L; Department of Hematology and Oncology, University Cancer Center Hamburg (UCCH), University Medical Center Eppendorf, Hamburg, Germany., Benedikter B; Institute for Lung Research, Universities of Giessen and Marburg Lung Centre, Philipps-University Marburg, German Center for Lung Research (DZL), Marburg, Germany; University Eye Clinic Maastricht, MHeNs School for Mental Health and Neuroscience, Maastricht University Medical Center + (MUMC+), Maastricht, the Netherlands., Bolis S; Cardiovascular Theranostics, Istituto Cardiocentro Ticino, Laboratories for Translational Research, Ente Ospedaliero Cantonale, Bellinzona, Switzerland., Bouriche T; Research and Technology Department, BioCytex, Marseille, France., Brambilla M; Centro Cardiologico Monzino IRCCS, Milan, Italy., Burrello J; Cardiovascular Theranostics, Istituto Cardiocentro Ticino, Laboratories for Translational Research, Ente Ospedaliero Cantonale, Bellinzona, Switzerland., Camera M; Centro Cardiologico Monzino IRCCS, Milan, Italy; Department of Pharmaceutical Sciences, Università degli Studi di Milano, Milan, Italy., Campello E; Department of Medicine, University of Padova, Padua, Italy., Ettelaie C; Biomedical Science, University of Hull/HYMS, Cottingham Road, Hull, United Kingdom., Faille D; Université Paris Cité and Université Sorbonne Paris Nord, INSERM, LVTS, Paris, France; Laboratoire d'Hématologie, AP-HP, Hôpital Bichat, Paris, France., Featherby S; Biomedical Science, University of Hull/HYMS, Cottingham Road, Hull, United Kingdom., Franco C; Research and Technology Department, BioCytex, Marseille, France., Guldenpfennig M; Université Catholique de Louvain, CHU UCL NAMUR, Namur Thrombosis and Hemostasis Center (NTHC), Yvoir, Belgium., Hansen JB; Thrombosis Research Group (TREC), Institute of Clinical Medicine, UiT - The Arctic University of Norway, Tromsø, Norway; Thrombosis Research Center (TREC), Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway., Judicone C; Research and Technology Department, BioCytex, Marseille, France., Kim Y; epartment of Urology, Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA., Kristensen SR; Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark., Laakmann K; Institute for Lung Research, Universities of Giessen and Marburg Lung Centre, Philipps-University Marburg, German Center for Lung Research (DZL), Marburg, Germany., Langer F; Department of Hematology and Oncology, University Cancer Center Hamburg (UCCH), University Medical Center Eppendorf, Hamburg, Germany., Latysheva N; Thrombosis Research Group (TREC), Institute of Clinical Medicine, UiT - The Arctic University of Norway, Tromsø, Norway., Lucien F; epartment of Urology, Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA., de Menezes EM; Vitalant Research Institute, San Francisco, California, USA; Department of Laboratory Medicine, University of California, San Francisco, California, USA., Mullier F; Université Catholique de Louvain, CHU UCL NAMUR, Namur Thrombosis and Hemostasis Center (NTHC), Yvoir, Belgium., Norris P; Vitalant Research Institute, San Francisco, California, USA; Department of Laboratory Medicine, University of California, San Francisco, California, USA; Department of Medicine, UCSF, San Francisco, California, USA., Nybo J; Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark., Orbe J; Laboratory of Atherothrombosis, Program of Cardiovascular Diseases, Cima Universidad de Navarra, Pamplona, Spain; IdiSNA, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain; RICORS-Cerebrovascular Diseases, Instituto de Salud Carlos III, Madrid, Spain., Osterud B; Thrombosis Research Group (TREC), Institute of Clinical Medicine, UiT - The Arctic University of Norway, Tromsø, Norway., Paramo JA; Centro de Investigación Biomédica en Red Cardiovascular (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain; Laboratory of Atherothrombosis, Program of Cardiovascular Diseases, Cima Universidad de Navarra, Pamplona, Spain; IdiSNA, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain., Radu CM; Department of Medicine, University of Padova, Padua, Italy., Roncal C; Centro de Investigación Biomédica en Red Cardiovascular (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain; Laboratory of Atherothrombosis, Program of Cardiovascular Diseases, Cima Universidad de Navarra, Pamplona, Spain; IdiSNA, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain; RICORS-Cerebrovascular Diseases, Instituto de Salud Carlos III, Madrid, Spain., Samadi N; Clinical Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Snir O; Thrombosis Research Group (TREC), Institute of Clinical Medicine, UiT - The Arctic University of Norway, Tromsø, Norway., Suades R; Cardiovascular ICCC Program, Research Institute Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red Cardiovascular (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain., Wahlund C; Thrombosis Research Group (TREC), Institute of Clinical Medicine, UiT - The Arctic University of Norway, Tromsø, Norway., Chareyre C; Aix-Marseille University, C2VN, INSERM 1263, INRAE1260, Marseille, France., Abdili E; Department of Hematology and Vascular Biology, CHU La Conception, APHM, Marseille, France., Martinod K; Center for Molecular and Vascular Biology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium., Thaler J; Clinical Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Dignat-George F; Aix-Marseille University, C2VN, INSERM 1263, INRAE1260, Marseille, France; Department of Hematology and Vascular Biology, CHU La Conception, APHM, Marseille, France. Electronic address: francoise.dignat-george@univ-amu.fr., Nieuwland R; Laboratory of Experimental Clinical Chemistry, and Amsterdam Vesicle Center, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Lacroix R; Aix-Marseille University, C2VN, INSERM 1263, INRAE1260, Marseille, France; Department of Hematology and Vascular Biology, CHU La Conception, APHM, Marseille, France.

Publikováno v: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2024 Oct; Vol. 22 (10), pp. 2910-2921. Date of Electronic Publication: 2024 Jun 25.

Lack of TAFI increases brain damage and microparticle generation after thrombolytic therapy in ischemic stroke

Autor: Orbe, J. ^{a, ⁎}, Alexandru, N. ^b, Roncal, C. ^a, Belzunce, M. ^a, Bibiot, P. ^a, Rodriguez, J.A. ^a, Meijers, J.C.M. ^{c, d}, Georgescu, A. ^b, Paramo, J.A. ^a

Publikováno v: In Thrombosis Research August 2015 136(2):445-450